1. Siegel RL, Miller KD, Jemal A. Cancer statistics, 2020. CA Cancer J Clin. 2020;Mar 5:doi: 10.3322/caac.21601. [Epub ahead of print].
2. Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394–424.
3. Chow FCL, Chok KSH. Colorectal liver metastases: An update on multidisciplinary approach. World J Hepatol. 2019;11(2):150–72.
4. East JE, Atkin WS, Bateman AC, Clark SK, Dolwani S, Ket SN, et al. British Society of Gastroenterology position statement on serrated polyps in the colon and rectum. Gut. 2017;66(7):1181–96.
5. Paschos KA, Majeed AW, Bird NC. Natural history of hepatic metastases from colorectal cancer - Pathobiological pathways with clinical significance. World J Gastroenterol. 2014;20(14):3719–37.
6. Li B, Huang Q, Wei GH. The role of hox transcription factors in cancer predisposition and progression. Cancers (Basel). 2019;11(4):528.
7. Castelli-Gair Hombría J, Lovegrove B. Beyond homeosis - HOX function in morphogenesis and organogenesis. Differentiation. 2003;71(8):461–76.
8. J. Durston A, Wacker S, Bardine N, J. Jansen H. Time Space Translation: A Hox Mechanism for Vertebrate A-P Patterning. Curr Genomics. 2012;13(4):300–7.
9. Quinonez SC, Innis JW. Human HOX gene disorders. Mol Genet Metab. 2014;111(1):4–15.
10. Bhatlekar S, Fields JZ, Boman BM. HOX genes and their role in the development of human cancers. J Mol Med. 2014 Aug;92(8):811–23.
11. Collins CT, Hess JL. Role of HOXA9 in leukemia: Dysregulation, cofactors and essential targets. Oncogene. 2016;35(9):1090–8.
12. Gilbert PM, Mouw JK, Unger MA, Lakins JN, Gbegnon MK, Clemmer VB, et al. HOXA9 regulates BRCA1 expression to modulate human breast tumor phenotype. J Clin Invest. 2010;120(5):1535–50.
13. Zhang L, Wu Q, He C, Liang D, Yi Q, Shi J, et al. HOXB9 inhibits proliferation in gastric carcinoma cells via suppression of phosphorylated-Akt and NF-κB-dependent Snail expression. Dig Liver Dis. 2019;51(1):157–65.
14. Hayashida T, Takahashi F, Chiba N, Brachtel E, Takahashi M, Godin-Heymann N, et al. HOXB9, a gene overexpressed in breast cancer, promotes tumorigenicity and lung metastasis. Proc Natl Acad Sci U S A. 2010;107(3):1100–5.
15. Haria D, Naora H. Homeobox Gene Deregulation: Impact on the Hallmarks of Cancer. Cancer Hallm. 2014;1(2–3):67–76.
16. Bhatlekar S, Fields JZ, Boman BM. Role of HOX genes in stem cell differentiation and cancer. Stem Cells Int. 2018;22;2018:3569493. doi: 10.1155/2018/3569493.
17. Javed S, Langley SEM. Importance of HOX genes in normal prostate gland formation, prostate cancer development and its early detection. BJU International. 2014. p. 113(4):535-40.
18. Liberati A, Altman DG, Tetzlaff J, Mulrow C, Gøtzsche PC, Ioannidis JPA, et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: Explanation and elaboration. J Clin Epidemiol. 2009;62(10):e1-34.
19. Zeng X, Zhang Y, Kwong JSW, Zhang C, Li S, Sun F, et al. The methodological quality assessment tools for preclinical and clinical studies, systematic review and meta-analysis, and clinical practice guideline: A systematic review. J Evid Based Med. 2015;8(1):2–10.
20. Hooijmans CR, Rovers MM, De Vries RBM, Leenaars M, Ritskes-Hoitinga M, Langendam MW. SYRCLE’s risk of bias tool for animal studies. BMC Med Res Methodol. 2014;14: 43:doi: 10.1186/1471-2288-14-43.
21. Liu M, Xiao Y, Tang W, Li J, Hong L, Dai W, et al. HOXD9 promote epithelial-mesenchymal transition and metastasis in colorectal carcinoma. Cancer Med. 2020;9(11):3932–43.
22. Cui Y, Zhang C, Wang Y, Ma S, Cao W, Guan F. HOXC11 functions as a novel oncogene in human colon adenocarcinoma and kidney renal clear cell carcinoma. Life Sci. 2020;243:117230.
23. Zhang X, Liu G, Ding L, Jiang T, Shao S, Gao Y, et al. HOXA3 promotes tumor growth of human colon cancer through activating EGFR/Ras/Raf/MEK/ERK signaling pathway. J Cell Biochem. 2018;119(3):2864–74.
24. Carbone C, Piro G, Simionato F, Ligorio F, Cremolini C, Loupakis F, et al. Homeobox B9 mediates resistance to anti-VEGF therapy in colorectal cancer patients. Clin Cancer Res. 2017;23(15):4312–22.
25. Ji M, Feng Q, He G, Yang L, Tang W, Lao X, et al. Silencing homeobox C6 inhibits colorectal cancer cell proliferation. Oncotarget. 2016;7(20):29216–27.
26. Wang Y, Li Z, Zhao X, Zuo X, Peng Z. MiR-10b promotes invasion by targeting HOXD10 in colorectal cancer. Oncol Lett. 2016;12(1):488–94.
27. Shen S, Pan J, Lu X, Chi P. Role of miR-196 and its target gene HoxB8 in the development and proliferation of human colorectal cancer and the impact of neoadjuvant chemotherapy with FOLFOX4 on their expression. Oncol Lett. 2016;12(5):4041–7.
28. Hoshino Y, Hayashida T, Hirata A, Takahashi H, Chiba N, Ohmura M, et al. Bevacizumab terminates homeobox B9-induced tumor proliferation by silencing microenvironmental communication. Mol Cancer. 2014;5;13:102.
29. Zhan J, Niu M, Wang P, Zhu X, Li S, Song J, et al. Elevated HOXB9 expression promotes differentiation and predicts a favourable outcome in colon adenocarcinoma patients. Br J Cancer. 2014;111(5):883–93.
30. Huang K, Yuan R, Wang K, Hu J, Huang Z, Yan C, et al. Overexpression of HOXB9 promotes metastasis and indicates poor prognosis in colon cancer. Chinese J Cancer Res. 2014;26(1):72–80.
31. Liao WT, Jiang D, Yuan J, Cui YM, Shi XW, Chen CM, et al. HOXB7 as a prognostic factor and mediator of colorectal cancer progression. Clin Cancer Res. 2011;17(11):3569–78.
32. Kanai M, Hamada JI, Takada M, Asano T, Murakawa K, Takahashi Y, et al. Aberrant expressions of HOX genes in colorectal and hepatocellular carcinomas. Oncol Rep. 2010;23(3):843–51.
33. Ying Y, Wang Y, Huang X, Sun Y, Zhang J, Li M, et al. Oncogenic HOXB8 is driven by MYC-regulated super-enhancer and potentiates colorectal cancer invasiveness via BACH1. Oncogene. 2020;39:1004–17.
34. Cantile M, Franco R, Tschan A, Baumhoer D, Zlobec I, Schiavo G, et al. HOX D13 expression across 79 tumor tissue types. Int J Cancer. 2009;125(7):1532–41.
35. Groene J, Mansmann U, Meister R, Staub E, Roepcke S, Heinze M, et al. Transcriptional census of 36 microdissected colorectal cancers yields a gene signature to distinguish UICC II and III. Int J Cancer. 2006;119(8):1829–36.
36. Jung C, Kim RS, Zhang H, Lee SJ, Sheng H, Loehrer PJ, et al. HOXB13 is downregulated in colorectal cancer to confer TCF4-mediated transactivation. Br J Cancer. 2005;92(12):2233–9.
37. Toiyama Y, Mizoguchi A, Kimura K, Araki T, Yoshiyama S, Sakaguchi K, et al. Persistence of gene expression changes in noninflamed and inflamed colonic mucosa in ulcerative colitis and their presence in colonic carcinoma. World J Gastroenterol. 2005;11(33):5151–5.
38. Vider BZ, Zimber A, Hirsch D, Estlein D, Chastre E, Prevot S, et al. Human colorectal carcinogenesis is associated with deregulation of homeobox gene expression. Biochem Biophys Res Commun. 1997;232(3):742–8.
39. Wu S, Wu F, Jiang Z. Effect of HOXA6 on the proliferation, apoptosis, migration and invasion of colorectal cancer cells. Int J Oncol. 2018;52(6):2093–100.
40. Yuan Y, Sun S, Jiao N, Shu Y, Zhang Y. Upregulation of HOXA10 Protein Expression Predicts Poor Prognosis for Colorectal Cancer. Genet Test Mol Biomarkers. 2018;22(6):1–8.
41. Tatangelo F, Di Mauro A, Scognamiglio G, Aquino G, Lettiero A, Delrio P, et al. Posterior HOX genes and HOTAIR expression in the proximal and distal colon cancer pathogenesis. J Transl Med. 2018;16(1):350.
42. Song J, Wang T, Xu W, Wang P, Wan J, Wang Y, et al. HOXB9 acetylation at K27 is responsible for its suppression of colon cancer progression. Cancer Lett. 2018;10;426:63–72.
43. Bhatlekar S, Fields JZ, Boman BM. Role of HOX genes in stem cell differentiation and cancer. Stem Cells Int. 2018;22;2018:35.
44. Watanabe Y, Saito M, Saito K, Matsumoto Y, Kanke Y, Onozawa H, et al. Upregulated HOXA9 expression is associated with lymph node metastasis in colorectal cancer. Oncol Lett. 2018;15(3):2756–62.
45. Mansour MA, Senga T. HOXD8 exerts a tumor-suppressing role in colorectal cancer as an apoptotic inducer. Int J Biochem Cell Biol. 2017;88:1–13.
46. Li H, Zhu G, Xing Y, Zhu Y, Piao D. miR-4324 functions as a tumor suppressor in colorectal cancer by targeting HOXB2. J Int Med Res. 2020;48(3):300060519883731.
47. Li H, Li J, Yang T, Lin S, Li H. MicroRNA-433 represses proliferation and invasion of colon cancer cells by targeting homeobox A1. Oncol Res. 2018;26(2):315–22.
48. Bhatlekar S, Viswanathan V, Fields JZ, Boman BM. Overexpression of HOXA4 and HOXA9 genes promotes self-renewal and contributes to colon cancer stem cell overpopulation. J Cell Physiol. 2018;233(2):727–35.
49. Han Y, Zhao Q, Zhou J, Shi R. miR-429 mediates tumor growth and metastasis in colorectal cancer. Am J Cancer Res. 2017;7(2):218–33.
50. Chen F, Sun G, Peng J. RNAi-mediated HOXD3 knockdown inhibits growth in human RKO cells. Oncol Rep. 2016;36(4):1793–8.
51. Kasiri S, Ansari KI, Hussain I, Bhan A, Mandal SS. Antisense oligonucleotide mediated knockdown of HOXC13 affects cell growth and induces apoptosis in tumor cells and over expression of HOXC13 induces 3D-colony formation. RSC Adv. 2013;3(10):3260–9.
52. Sun S, Su C, Zhu Y, Li H, Liu N, Xu T, et al. MicroRNA-544a Regulates Migration and Invasion in Colorectal Cancer Cells via Regulation of Homeobox A10. Dig Dis Sci. 2016;61(9):2535–44.
53. Ghoshal K, Motiwala T, Claus R, Yan P, Kutay H, Datta J, et al. HOXB13, a target of DNMT3B, is methylated at an upstream CpG island, and functions as a tumor suppressor in primary colorectal tumors. PLoS One. 2010;5(4):e10338.
54. Saad El Din K, Loree JM, Sayre EC, Gill S, Brown CJ, Dau H, et al. Trends in the epidemiology of young-onset colorectal cancer: A worldwide systematic review. BMC Cancer. 2020;20(1:288):doi: 10.1186/s12885-020-06766-9.
55. Jin X, Dai L, Ma Y, Wang J, Yan H, Jin Y, et al. Homeobox proteins are potential biomarkers and therapeutic targets in gastric cancer: A systematic review and meta-analysis. BMC Cancer. 2020;20(1):866. doi: 10.1186/s12885-020-07346–7.
56. Yu M, Zhan J, Zhang H. HOX family transcription factors: Related signaling pathways and post-translational modifications in cancer. Cell Signal. 2020;66:doi: 10.1016/j.cellsig.2019.109469.
57. Kachgal S, Mace KA, Boudreau NJ. The dual roles of homeobox genes in vascularisation and wound healing. Cell Adhes Migr. 2012;6(6):457–70.
58. Wan J, Xu W, Zhan J, Ma J, Li X, Xie Y, et al. PCAF-mediated acetylation of transcriptional factor HOXB9 suppresses lung adenocarcinoma progression by targeting oncogenic protein JMJD6. Nucleic Acids Res. 2016;44(22):10662–75.
59. Ladam F, Sagerström CG. Hox regulation of transcription: More complex(es). Dev Dyn. 2014;243(1):4–15.
60. Contarelli S, Fedele V, Melisi D. HOX genes family and cancer: A novel role for homeobox B9 in the resistance to anti-angiogenic therapies. Cancers (Basel). 2020;21(11):3299, doi: 10.3390/cancers12113299.
61. Morgan R, El-Tanani M, Hunter KD, Harrington KJ, Pandha HS. Targeting HOX/PBX dimers in cancer. Oncotarget. 2017;8(19):32322–31.